Cold, Flu & Cough News and Research

Latest Cold, Flu & Cough News and Research

Sarcopenia and COVID-19

Sarcopenia and COVID-19

Bioinformatics pipeline can be used to quickly identify SARS-CoV-2 therapeutics

Bioinformatics pipeline can be used to quickly identify SARS-CoV-2 therapeutics

Study suggests pre-existing human common cold coronavirus antibodies hinder SARS-CoV-2 immunity

Study suggests pre-existing human common cold coronavirus antibodies hinder SARS-CoV-2 immunity

Seasonal coronaviruses may help estimate SARS-CoV-2 reinfection risk

Seasonal coronaviruses may help estimate SARS-CoV-2 reinfection risk

Researchers develop a universal SARS-CoV-2 neutralizing antibody

Researchers develop a universal SARS-CoV-2 neutralizing antibody

How LA, calling the shots on school vaccine mandates, can lead the way on covid rules

How LA, calling the shots on school vaccine mandates, can lead the way on covid rules

Nasal infection drives lethal lung injury due to SARS-CoV-2 in mice

Nasal infection drives lethal lung injury due to SARS-CoV-2 in mice

Statistical model builds SARS-CoV-2 interactome with miRNAs, protein-coding genes, and co-infecting microbes

Statistical model builds SARS-CoV-2 interactome with miRNAs, protein-coding genes, and co-infecting microbes

A pandemic-scale phylogenetic analysis tool

A pandemic-scale phylogenetic analysis tool

A new rapid and inexpensive PCR method to detect SARS-CoV-2 Omicron variant

A new rapid and inexpensive PCR method to detect SARS-CoV-2 Omicron variant

Infant immune system beats the adult immune system at fighting off new pathogens

Infant immune system beats the adult immune system at fighting off new pathogens

Formula 1's biggest stars urge all fans to get their COVID-19 vaccine

Formula 1's biggest stars urge all fans to get their COVID-19 vaccine

Nasal vaccine provides broad-based protection against heterologous respiratory viruses in mice

Nasal vaccine provides broad-based protection against heterologous respiratory viruses in mice

UCLA research points the way towards a longer-lasting COVID vaccine

UCLA research points the way towards a longer-lasting COVID vaccine

COVID-19 booster program accelerated, 22 million people in the UK have received top-up jabs

COVID-19 booster program accelerated, 22 million people in the UK have received top-up jabs

Maternal and neonatal cord-blood antibody profile in response to SARS-CoV-2

Maternal and neonatal cord-blood antibody profile in response to SARS-CoV-2

Symptoms after a third mRNA vaccine among patients with inflammatory bowel disease

Symptoms after a third mRNA vaccine among patients with inflammatory bowel disease

Positive results from Phase 3 study of Medicago’s plant-based COVID-19 vaccine candidate announced

Positive results from Phase 3 study of Medicago’s plant-based COVID-19 vaccine candidate announced

Characterization of the baseline SARS-CoV-2 S-reactive B cell repertoire

Characterization of the baseline SARS-CoV-2 S-reactive B cell repertoire

AI-based technology to identify patients at risk of serious illness as a result of blood infections

AI-based technology to identify patients at risk of serious illness as a result of blood infections

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.